Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Am J Obstet Gynecol
    September 2024
  1. PROVINCIATTO H, Meirelles Dias YJ, Abonizio Magdalena SL, Barbosa Moreira MV, et al
    Immediate versus delayed postpartum insertion of long-acting reversible contraception methods: meta-analysis of randomized controlled trials.
    Am J Obstet Gynecol. 2024 Sep 18:S0002-9378(24)00931.
    >> Share

    August 2024
  2. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    Effect of Covid-19 pandemic on postpartum depression and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00843.
    >> Share

  3. RIDGEWELL B, Callins K
    Postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00842.
    >> Share

  4. CHAPPELL CA, Lamorde M, Nakalema S, Kyohairwe I, et al
    A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.
    Am J Obstet Gynecol. 2024;231:242.
    >> Share

    July 2024
  5. SUZUKI Y, Ferris JS, Chen L, Dioun S, et al
    Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2024 Jul 18:S0002-9378(24)00761.
    >> Share

  6. RICKER EA, Koltun KJ, DE LA Motte SJ
    Female Service Members Deserve an Individualized Approach to Hormonal Contraception Counseling.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00752.
    >> Share

  7. KINKAID V, Morris K, Guest R
    Hormonal Contraception and Medical Readiness for Female Service Members: A comment.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00751.
    >> Share

  8. KERNS JL, Keder LM, Cwiak CA, Westhoff CL, et al
    Hormone-related side effects in new users of a levonorgestrel 52 mg intrauterine device.
    Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00743.
    >> Share

    June 2024
  9. MILLER CE, Kim JH, Kroll R, Simon JA, et al
    Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial.
    Am J Obstet Gynecol. 2024 Jun 30:S0002-9378(24)00731.
    >> Share

    May 2024
  10. RICKER EA, Koltun KJ, de la Motte SJ
    Hormonal Contraception and Medical Readiness for Female Service Members.
    Am J Obstet Gynecol. 2024 May 27:S0002-9378(24)00630.
    >> Share

  11. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    >> Share

  12. AMES JL, Anderson MC, Cronbach E, Lee C, et al
    Reproductive healthcare in adolescents with autism and other developmental disabilities.
    Am J Obstet Gynecol. 2024;230:546.
    >> Share

    April 2024
  13. LO FARO V, Johansson A
    Genotyping oral contraceptive users for venous thromboembolism risk.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00565.
    >> Share

  14. VERCELLINI P, Artoni A, Abbattista M, Martinelli I, et al
    PREDICTION OF VENOUS THROMBOEMBOLISM IN AVERAGE-RISK YOUNG CANDIDATES FOR ORAL CONTRACEPTIVE USE: TO GENOTYPE, OR NOT TO GENOTYPE, THAT IS THE QUESTION.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00564.
    >> Share

    March 2024
  15. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    The association between postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Mar 27:S0002-9378(24)00472.
    >> Share

  16. SANCHEZ-RAMOS L, Levine LD, Sciscione AC, Mozurkewich EL, et al
    Methods for the induction of labor: efficacy and safety.
    Am J Obstet Gynecol. 2024;230.
    >> Share

  17. CHESNOKOVA A, Christensen T, Streaty T, McAllister A, et al
    Medicaid compared to private insurance is associated with lower rates of sterilization in people with unwanted births.
    Am J Obstet Gynecol. 2024;230:347.
    >> Share

    February 2024
  18. TORRES E, Carter G, Gero A, Simmons RG, et al
    Frequency of same-day start contraceptive initiation, recent unprotected intercourse, and pregnancy risk: a prospective cohort study of multiple contraceptive methods.
    Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00083.
    >> Share

    January 2024
  19. PLAGIANOS MG, Ramanadhan S, Merkatz RB, Brache V, et al
    Risk Factors for and Outcomes of Ring Expulsions with a One Year Contraceptive Vaginal System.
    Am J Obstet Gynecol. 2024 Jan 29:S0002-9378(24)00061.
    >> Share

  20. HUIJS DPC, Derickx AJM, Beelen P, Leemans JC, et al
    A 52 mg levonorgestrel-releasing intrauterine system versus bipolar radiofrequency non-resectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multi-center randomized controlled trial.
    Am J Obstet Gynecol. 2024 Jan 25:S0002-9378(24)00045.
    >> Share

    December 2023
  21. GUO XM, Lim LM, Matsuzaki S, Matsuo K, et al
    Research on intrauterine manipulators for endometrial cancer: Attention to study-level characteristics.
    Am J Obstet Gynecol. 2023 Dec 8:S0002-9378(23)02122.
    >> Share

    October 2023
  22. DANVERS AA, Gurney EG, Panushka K, Peskin M, et al
    Shortcomings and Disparities in Contraception Counseling and Use by Hypertensive Individuals at Risk for Unintended Pregnancy: A Comparative Analysis of the National Survey of Family Growth 2015-2019.
    Am J Obstet Gynecol. 2023 Oct 21:S0002-9378(23)00768.
    >> Share

    September 2023
  23. LO FARO V, Johansson T, Johansson A
    The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Am J Obstet Gynecol. 2023 Sep 19:S0002-9378(23)00618.
    >> Share

    August 2023
  24. MATTESON KA, Valcin J, Raker CA, Clark MA, et al
    A randomized trial comparing the 52-mg levonorgestrel system to combination oral contraceptives for treatment of heavy menstrual bleeding.
    Am J Obstet Gynecol. 2023 Aug 1:S0002-9378(23)00521.
    >> Share

    July 2023
  25. EASTIN EF, Nelson DA, Shaw JG, Shaw KA, et al
    Postpartum long-acting reversible contraceptive use among active-duty, female U.S. Army soldiers.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00471.
    >> Share

  26. CATHCART AM, Nezhat FR, Fitch KC, Nguyen CGT, et al
    Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00467.
    >> Share

  27. CREININ MD, Jensen JT
    Extending use of levonorgestrel 52 mg intrauterine device to 8 years.
    Am J Obstet Gynecol. 2023;229:84.
    >> Share

  28. GOLDBERG AB
    Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years.
    Am J Obstet Gynecol. 2023;229:85.
    >> Share

    June 2023
  29. SWAN LET, Cutler AS, Higgins JA
    Response to Letter to the Editor Regarding Physician Beliefs about Contraceptives as Abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00412.
    >> Share

  30. BEITER KA, Stanford JB
    Contraceptives as abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00411.
    >> Share

    April 2023
  31. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
    Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
    >> Share

    March 2023
  32. PHILLIPS AM, Rachad S, Flink-Bochacki R
    The association between abortion restrictions and patient-centered care for early pregnancy loss at U.S. OB/GYN residency programs.
    Am J Obstet Gynecol. 2023 Mar 30:S0002-9378(23)00223.
    >> Share

  33. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    >> Share

  34. ZHANG J, Zhu C, Yan L, Wang Y, et al
    Comparing levonorgestrel intrauterine system versus hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open label, controlled trial.
    Am J Obstet Gynecol. 2023 Mar 17:S0002-9378(23)00167.
    >> Share

  35. LEVINE EM
    Extended use of the Levonorgestrel Intrauterine System for Contraception.
    Am J Obstet Gynecol. 2023 Mar 16:S0002-9378(23)00160.
    >> Share

  36. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    >> Share

    February 2023
  37. RODRIGUEZ MI, Meath T, Watson K, Daly A, et al
    Predicted changes in travel distance for abortion among counties with low rates of effective contraceptive use following Dobbs v Jackson.
    Am J Obstet Gynecol. 2023 Feb 2:S0002-9378(23)00072.
    >> Share

    December 2022
  38. MCCOLL R, Gifford K, Joan McDuffie M, Boudreaux M, et al
    Same-day long-acting reversible contraceptive utilization after a statewide contraceptive access initiative.
    Am J Obstet Gynecol. 2022 Dec 21:S0002-9378(22)02582.
    >> Share

  39. HEALY A, Davidson C, Allbert J, Bauer S, et al
    Telemedicine in obstetrics, quality and safety considerations.
    Am J Obstet Gynecol. 2022 Dec 5:S0002-9378(22)02261.
    >> Share

    November 2022
  40. KAISER JE, Turok DK, Gero A, Gawron LM, et al
    One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: A randomized controlled trial.
    Am J Obstet Gynecol. 2022 Nov 22:S0002-9378(22)02189.
    >> Share

    October 2022
  41. FELS LM, Costescu D, Vieira CS, Peipert JF, et al
    The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Am J Obstet Gynecol. 2022 Oct 29:S0002-9378(22)00835.
    >> Share

    September 2022
  42. SWAN LET, Cutler AS, Lands M, Schmuhl NB, et al
    Physician Beliefs about Contraceptive Methods as Abortifacients.
    Am J Obstet Gynecol. 2022 Sep 28. pii: S0002-9378(22)00772.
    >> Share

  43. JENSEN JT, Lukkari-Lax E, Schulze A, Wahdan Y, et al
    Contraceptive efficacy and safety of 52mg LNG-IUS for up to 8 years: findings from the Mirena Extension Trial.
    Am J Obstet Gynecol. 2022 Sep 9. pii: S0002-9378(22)00729.
    >> Share

    August 2022
  44. HOGMARK S, Lichtenstein Liljeblad K, Envall N, Gemzell-Danielsson K, et al
    Placement of an intrauterine device within 48 hours after early medical abortion - a randomized controlled trial.
    Am J Obstet Gynecol. 2022 Aug 12. pii: S0002-9378(22)00646.
    >> Share

  45. HENKEL A, Lerma K, Reyes G, Gutow H, et al
    Lactogenesis and breastfeeding after immediate versus delayed birth-hospitalization insertion of etonogestrel contraceptive implant: A non-inferiority trial.
    Am J Obstet Gynecol. 2022 Aug 11. pii: S0002-9378(22)00644.
    >> Share

    July 2022
  46. MILLER R, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine Consult Series #63: Cesarean scar ectopic pregnancy.
    Am J Obstet Gynecol. 2022 Jul 15. pii: S0002-9378(22)00478.
    >> Share

    June 2022
  47. NAGENDRA D, Gutman SM, Koelper NC, Loza-Avalos SE, et al
    Medical management of early pregnancy loss is cost-effective compared to office uterine aspiration.
    Am J Obstet Gynecol. 2022 Jun 30. pii: S0002-9378(22)00530.
    >> Share

  48. GOUETH RC, Maki KG, Babatunde A, Eden KB, et al
    Effects of Technology-Based Contraceptive Decision Aids: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2022 Jun 29. pii: S0002-9378(22)00526.
    >> Share

  49. TOFFOL E, Heikinheimo O, Jousilahti P, But A, et al
    Metabolomics profile of 5649 users and non-users of hormonal intrauterine devices in Finland.
    Am J Obstet Gynecol. 2022 Jun 10. pii: S0002-9378(22)00455.
    >> Share

  50. VAN BIEMA F, Friedman AM, Cepin AG, Wen T, et al
    Trends in Use of Long-Acting Reversible Contraception during Delivery Hospitalizations, 2000-2019.
    Am J Obstet Gynecol. 2022 Jun 3. pii: S0002-9378(22)00436.
    >> Share

    May 2022
  51. FANG NZ, Westhoff CL
    Update on Incidence of Inpatient Tubal Ligation and Long-acting Reversible Contraception in the United States.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00365.
    >> Share

  52. CREININ MD, Schreiber CA, Turok DK, Cwiak C, et al
    Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00366.
    >> Share

    April 2022
  53. GATZ JL, Armstrong MA, Postlethwaite D, Raine-Bennett T, et al
    Association Between Intrauterine Device Type and Risk of Perforation and Device Expulsion: Results From the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Apr 5. pii: S0002-9378(22)00264.
    >> Share

    March 2022
  54. MONIZ MH, Peahl AF, Dawn Zinsser M, Kolenic MGE, et al
    Social Vulnerability and Utilization of Postpartum Long-acting Reversible Contraception and Sterilization.
    Am J Obstet Gynecol. 2022 Mar 18. pii: S0002-9378(22)00202.
    >> Share

  55. GETAHUN D, Fassett MJ, Gatz J, Armstrong MA, et al
    Association Between Menorrhagia and Risk of Intrauterine Device-Related Uterine Perforation and Device Expulsion: Results from the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Mar 12. pii: S0002-9378(22)00197.
    >> Share

  56. THORNTON M, Ascha MS, Arora KS
    Addressing Fluidity in Contraceptive Decision-Making: A Key Component of Patient-Centered Contraceptive Counseling.
    Am J Obstet Gynecol. 2022 Mar 3. pii: S0002-9378(22)00160.
    >> Share

    December 2021
  57. FANG NZ, Advaney SP, Castano PM, Davis A, et al
    Female Permanent Contraception Trends and Updates.
    Am J Obstet Gynecol. 2021 Dec 29. pii: S0002-9378(21)02956.
    >> Share

  58. RALPH LJ, Ehrenreich K, Barar R, Biggs MA, et al
    Accuracy of self-assessment of gestational duration among people seeking abortion.
    Am J Obstet Gynecol. 2021 Dec 16. pii: S0002-9378(21)02683.
    >> Share

  59. BURCHARDT NA, Eliassen AH, Shafrir AL, Rosner B, et al
    Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
    Am J Obstet Gynecol. 2021 Dec 15. pii: S0002-9378(21)02686.
    >> Share

    October 2021
  60. KRAMER RD, Higgins JA, Everett B, Turok DK, et al
    A Prospective Analysis of the Relationship Between Sexual Acceptability and Contraceptive Satisfaction Over Time.
    Am J Obstet Gynecol. 2021 Oct 14. pii: S0002-9378(21)01109.
    >> Share

  61. MONIZ MH, Dalton VK, Smith RD, Owens LE, et al
    Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services.
    Am J Obstet Gynecol. 2021 Oct 13. pii: S0002-9378(21)01110.
    >> Share

  62. HESTER RH, Hortobagyi GN, Lim B
    Inflammatory breast cancer: early recognition and diagnosis is critical.
    Am J Obstet Gynecol. 2021;225:392-396.
    >> Share

    August 2021
  63. CHEN C, Strasser J, Banawa R, Luo Q, et al
    Who is providing contraception care in the United States? An Observational Study of the Contraception Workforce.
    Am J Obstet Gynecol. 2021 Aug 18. pii: S0002-9378(21)00883.
    >> Share

    July 2021
  64. DE WIT AE, DE Vries YA, DE Boer MK, Scheper C, et al
    Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
    Am J Obstet Gynecol. 2021 Jul 2. pii: S0002-9378(21)00774.
    >> Share

  65. RODRIGUEZ MI, Skye M, Edelman AB, Anderson L, et al
    Association of pharmacist prescription and 12 month contraceptive continuation rates.
    Am J Obstet Gynecol. 2021 Jul 1. pii: S0002-9378(21)00773.
    >> Share

    June 2021
  66. HARITON E, Shirazi TN, Douglas NC, Hershlag A, et al
    Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Am J Obstet Gynecol. 2021 Jun 11. pii: S0002-9378(21)00685.
    >> Share

    April 2021
  67. KAIMAL A, Norton ME
    Society for Maternal-Fetal Medicine Consult Series #55: Counseling women at increased risk of maternal morbidity and mortality.
    Am J Obstet Gynecol. 2021;224:B16-B23.
    >> Share

  68. YEE LM, Williams B, Green HM, Carmona-Barrera V, et al
    Bridging the postpartum gap: Best practices for training of obstetric patient navigators.
    Am J Obstet Gynecol. 2021 Apr 1. pii: S0002-9378(21)00218.
    >> Share

    March 2021
  69. MILLS K, Marchand G, Sainz K, Azadi A, et al
    Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2021;224:258-265.
    >> Share

    January 2021
  70. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    >> Share

    December 2020
  71. MERZ AA, Gutierrez-Sacristan A, Bartz D, Williams NE, et al
    Population attitudes toward contraceptive methods over time on a social media platform.
    Am J Obstet Gynecol. 2020 Dec 9. pii: S0002-9378(20)31378.
    >> Share

  72. RUSSELL CB, Evans ML, Qasba N, Frankel A, et al
    Medicaid sterilization consent forms: variation in rejection and payment consequences.
    Am J Obstet Gynecol. 2020;223:934-936.
    >> Share

    November 2020
  73. GO VAA, Thomas MC, Singh B, Prenatt S, et al
    A systematic review of the psychosocial impact of fibroids before and after treatment.
    Am J Obstet Gynecol. 2020;223:674-708.
    >> Share

    October 2020
  74. JOULAUD P, Pithois A, Ramanah R
    VAGINAL BLEEDING FROM AN UNIDENTIFIED SUSPICIOUS UTERINE TUMOR IN A YOUNG WOMAN.
    Am J Obstet Gynecol. 2020 Oct 13. pii: S0002-9378(20)31185.
    >> Share

  75. SCHULTHEIS P, Natalie Montoya M, Zhao Q, Archer J, et al
    Contraception and Ectopic Pregnancy Risk: A Prospective Observational Analysis.
    Am J Obstet Gynecol. 2020 Oct 10. pii: S0002-9378(20)31187.
    >> Share

  76. CHUNG YS, Woo HY, Lee JY, Park E, et al
    Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    Am J Obstet Gynecol. 2020 Oct 8. pii: S0002-9378(20)31175.
    >> Share

    September 2020
  77. BEDFORD L, Parker SE, Davis E, Salzman E, et al
    Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia.
    Am J Obstet Gynecol. 2020;223:406.
    >> Share

  78. SONG X, Wu J, Zhou Y, Feng L, et al
    Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women.
    Am J Obstet Gynecol. 2020;223:410.
    >> Share

    August 2020
  79. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    >> Share

  80. BEELEN P, VAN DEN Brink MJ, Herman MC, Geomini PM, et al
    Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2020 Aug 11. pii: S0002-9378(20)30844.
    >> Share

    April 2020
  81. SONALKAR S, Koelper N, Creinin MD, Atrio JM, et al
    Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial.
    Am J Obstet Gynecol. 2020 Apr 16. pii: S0002-9378(20)30431.
    >> Share

    January 2020
  82. MILLER R, Timor IE, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy.
    Am J Obstet Gynecol. 2020 Jan 20. pii: S0002-9378(20)30038.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016